Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin in Adults With COVID-19 Pneumonia
NCT04394208Phase 3Unknown
- Sponsor
- Cairo University
- Start
- Aug 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of silymarin in COVID-19 pneumonia, sponsored by Cairo University. Status: unknown.
02
Drugs
silymarin
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04394208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04394208.